
/s/ Leigh Curyer |
/s/ Benjamin Salter | |||||||
Leigh Curyer |
Benjamin Salter | |||||||
President and Chief Executive Officer |
Chief Financial Officer | |||||||
March 3, 2026 |
||||||||
Note |
December 31, 2025 |
December 31, 2024 | ||||||||
Assets |
||||||||||
Current assets |
||||||||||
Cash |
$ |
$ | |
|||||||
Short-term investments |
||||||||||
Amounts receivable |
||||||||||
Prepaid expenses and other assets |
||||||||||
Lease receivable |
||||||||||
Non-current assets |
||||||||||
Exploration and evaluation assets |
5 | |||||||||
Property and equipment |
6 | |||||||||
Investment in associate |
7 | |||||||||
Strategic inventory |
8 | |||||||||
Other non-current assets |
||||||||||
Total assets |
$ |
$ | ||||||||
Liabilities |
||||||||||
Current liabilities |
||||||||||
Accounts payable and accrued liabilities |
$ |
$ | ||||||||
Interest payable |
||||||||||
Lease liabilities |
||||||||||
Derivative liability |
13 | |||||||||
Convertible debentures |
9 | |||||||||
Non-current liabilities |
||||||||||
Long-term derivative liability |
13 | |||||||||
Other non-current liabilities |
||||||||||
Total liabilities |
$ |
$ | ||||||||
Equity |
||||||||||
Share capital |
10 | $ |
$ | |||||||
Reserves |
10 | |||||||||
Accumulated other comprehensive income (deficit) |
( |
|||||||||
Accumulated deficit |
( |
( |
||||||||
Total equity |
||||||||||
Total liabilities and equity |
$ |
$ | ||||||||
| The accompanying notes are an integral part of these consolidated financial statements. |
| 1 |
Note |
Twelve months ended Dec 31, |
|||||||||
2025 |
2024 | |||||||||
Expenses |
||||||||||
Salaries, benefits and directors’ fees |
$ |
$ | |
|||||||
Office, administrative, and travel |
||||||||||
Professional fees and insurance |
||||||||||
Depreciation |
6 | |||||||||
Share-based payments |
10(b) | |||||||||
( |
( |
|||||||||
Finance income |
||||||||||
Mark-to-market |
9 | ( |
||||||||
Interest expense on convertible debentures |
9 | ( |
( |
|||||||
Interest on lease liabilities and accretion expense |
( |
( |
||||||||
Share of net loss from associate |
7 | ( |
( |
|||||||
Loss on dilution of ownership interest in associate |
7 | ( |
( |
|||||||
Impairment loss on investment in associate |
7 | ( |
||||||||
Mark-to-market |
13 | ( |
||||||||
Foreign exchange gain (loss) |
( |
|||||||||
Other expense |
( |
|||||||||
Loss before taxes |
( |
( |
||||||||
Deferred income tax recovery (expense) |
14 | ( |
||||||||
Net loss |
( |
( |
||||||||
Items that may not be reclassified subsequently to profit or loss: |
||||||||||
Change in fair value of convertible debenture attributable to the change in credit risk |
9 | ( |
||||||||
Deferred income tax recovery (expense) |
( |
|||||||||
Share of other comprehensive income (loss) from associate |
7 | ( |
||||||||
Net comprehensive loss |
$ |
( |
$ | ( |
||||||
Loss per share |
||||||||||
Basic and diluted loss per share |
$ |
( |
$ | ( |
||||||
Weighted average common shares outstanding |
||||||||||
Basic and diluted |
||||||||||
| The accompanying notes are an integral part of these consolidated financial statements. |
| 2 |
Note |
||||||||||
2025 |
2024 | |||||||||
Net loss for the year: |
$ |
( |
$ | ( |
||||||
Adjust for: |
||||||||||
Depreciation |
6 | |||||||||
Share-based payments |
10(b) | |||||||||
Mark-to-market |
9 | ( |
||||||||
Interest expense on convertible debentures |
9 | |||||||||
Interest on lease liabilities and accretion expense |
||||||||||
Share of net loss from associate |
7 | |||||||||
Loss on dilution of ownership interest in associate |
7 | |||||||||
Impairment loss on investment in associate |
7 | |||||||||
Mark-to-market |
13 | |||||||||
Deferred income tax (recovery) expense |
14 | ( |
||||||||
Unrealized foreign exchange loss |
||||||||||
Finance income |
( |
|||||||||
Other expense |
||||||||||
Operating cash flows before working capital |
( |
( |
||||||||
Changes in working capital items: |
||||||||||
Amounts receivable |
( |
|||||||||
Prepaid expenses and other |
( |
( |
||||||||
Accounts payable and accrued liabilities |
( |
|||||||||
Cash used in operating activities |
$ |
( |
$ | ( |
||||||
Expenditures on exploration and evaluation assets |
5 | ( |
( |
|||||||
Acquisition of property and equipment |
6 | ( |
( |
|||||||
Acquisition of short-term investments |
( |
|||||||||
Investment in IsoEnergy |
7 | ( |
||||||||
Cash used in investing activities |
$ |
( |
$ | ( |
||||||
Proceeds from at-the-market |
10(a) | |||||||||
Proceeds from ASX CDI offering, net of issuance costs |
10(a) | |||||||||
Proceeds from global offering, net of issuance costs |
10(a) | |||||||||
Proceeds from exercise of stock options |
10(a) | |||||||||
Restricted cash |
13 | ( |
||||||||
Payment of lease liabilities |
( |
( |
||||||||
Interest paid on convertible debentures |
9 | ( |
( |
|||||||
Cash provided by financing activities |
$ |
$ | ||||||||
Effect of exchange rates on cash and cash equivalents |
( |
( |
||||||||
Increase in cash |
$ |
$ | ||||||||
Cash, beginning of year |
||||||||||
Increase in cash |
||||||||||
Cash, end of year |
$ |
$ | |
|||||||
| The accompanying notes are an integral part of these consolidated financial statements. |
| 3 |
Share Capital |
||||||||||||||||||||||||||
Common Shares |
||||||||||||||||||||||||||
Note |
Number |
Amount |
Reserves |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
Total |
||||||||||||||||||||
Balance at December 31, 2023 |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||||||||
At-the-market |
10 | – | – | – | ||||||||||||||||||||||
| Shares issued on ASX CDI Offering, net of issuance costs | 10 | – | – | – | ||||||||||||||||||||||
| Share-based payments | 10(b) | – | – | – | – | |||||||||||||||||||||
| Shares issued on exercise of stock options | 10(b) | ( |
) | – | – | |||||||||||||||||||||
| Shares issued for convertible debenture interest payments | 9 | – | – | – | ||||||||||||||||||||||
| Shares issued for convertible debentures establishment fee | 9 | – | – | – | ||||||||||||||||||||||
| Net loss | – | – | – | – | ( |
) | ( |
) | ||||||||||||||||||
| Other comprehensive income | – | – | – | |||||||||||||||||||||||
Balance at December 31, 2024 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||
Balance at December 31, 2024 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||
| Shares issued on global offering, net of issuance costs | 10 | – | – | – | ||||||||||||||||||||||
| Share-based payments | 10(b) | – | – | – | – | |||||||||||||||||||||
| Shares issued on exercise of stock options | 10(b) | ( |
) | – | – | |||||||||||||||||||||
| Shares issued for convertible debenture interest payments | 9 | – | – | – | ||||||||||||||||||||||
| Net loss | – | – | – | – | ( |
) | ( |
) | ||||||||||||||||||
| Other comprehensive loss | – | – | – | ( |
) | – | ( |
) | ||||||||||||||||||
Balance at December 31, 2025 |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||||||||
The accompanying notes are an integral part of these consolidated financial statements. |
4 |
1. |
REPORTING ENTITY |
2. |
NATURE OF OPERATIONS |
3. |
BASIS OF PREPARATION |
i. |
Share-based payments |
ii. |
Convertible debentures |
iii. |
Exploration and evaluation assets |
iv. |
Strategic Inventory |
v. |
Assessment of Control |
vi. |
Impairment Assessment of Investment in Associate |
4. |
MATERIAL ACCOUNTING POLICIES |
a) |
Functional and presentation currency |
b) |
Consolidation |
c) |
Investments in Associates |
d) |
Exploration and evaluation assets |
e) |
Inventories |
f) |
Impairment |
g) |
Decommissioning and restoration provisions |
h) |
Share capital |
i) |
Share-based payments |
j) |
Earnings (loss) per share |
k) |
Income taxes |
l) |
Financial instruments |
| i. | Classification |
| Financial assets/liabilities | Classification | |
| Cash | ||
| Amounts receivable | ||
| Short-term investments | ||
| Accounts payable and accrued liabilities | ||
| Derivative liability | ||
| Convertible debentures | ||
| ii. | Measurement |
| iii. | Impairment of financial assets at amortized cost |
| iv. | Derecognition |
m) |
Adoption of new accounting standards |
5. |
EXPLORATION AND EVALUATION ASSETS |
Rook I |
Other Athabasca Basin Properties |
Total | ||||||||||
Deferred exploration and acquisition costs |
||||||||||||
Balance at December 31, 2024 |
||||||||||||
Additions: |
||||||||||||
Camp and infrastructure |
||||||||||||
General exploration and drilling |
||||||||||||
Environmental, permitting, and engagement |
||||||||||||
Technical, engineering and design |
||||||||||||
Acquisition and other costs |
||||||||||||
Labour and wages |
||||||||||||
Share-based payments (Note 10(b)) |
||||||||||||
Asset retirement obligation assets |
||||||||||||
Total Additions |
||||||||||||
Balance at December 31, 2025 |
$ |
$ |
$ |
|||||||||
Rook I |
Other Athabasca Basin Properties |
Total | ||||||||||
Deferred exploration and acquisition costs |
||||||||||||
Balance at December 31, 2023 |
||||||||||||
Additions: |
||||||||||||
Camp and infrastructure |
||||||||||||
General exploration and drilling |
||||||||||||
Environmental, permitting, and engagement |
||||||||||||
Technical, engineering and design |
||||||||||||
Acquisition and other costs |
||||||||||||
Labour and wages |
||||||||||||
Share-based payments (Note 10(b)) |
||||||||||||
Total Additions |
||||||||||||
Balance at December 31, 2024 |
$ | |
$ | |
$ | |
||||||
6. |
PROPERTY AND EQUIPMENT |
Machinery and Equipment |
Computer Equipment and Software |
Other |
Total | |||||||||||||
Cost |
||||||||||||||||
As at December 31, 2023 |
$ | $ | $ | $ | ||||||||||||
Additions |
||||||||||||||||
Disposals |
( |
( |
||||||||||||||
As at December 31, 2024 |
$ | $ | $ | $ | ||||||||||||
Additions |
||||||||||||||||
Balance at December 31, 2025 |
$ |
$ |
$ |
$ |
||||||||||||
Accumulated Depreciation |
||||||||||||||||
As at December 31, 2023 |
$ | $ | $ | $ | ||||||||||||
Depreciation |
||||||||||||||||
As at December 31, 2024 |
$ | $ | $ | $ | ||||||||||||
Depreciation |
||||||||||||||||
Balance at December 31, 2025 |
$ |
$ |
$ |
$ |
||||||||||||
Net book value at December 31, 2024 |
$ |
$ |
$ |
$ |
||||||||||||
Net book value at December 31, 2025 |
$ |
$ |
$ |
$ |
||||||||||||
7. |
INVESTMENT IN ASSOCIATE |
Balance at December 31, 2023 |
$ |
|||
Loss on dilution of ownership interest in associate |
( |
|||
Share of net loss from associate |
( |
|||
Share of other comprehensive income from associate |
||||
Balance at December 31, 2024 |
$ |
|||
Loss on dilution of ownership interest in associate |
( |
|||
Share of net loss from associate |
( |
|||
Share of other comprehensive loss from associate |
( |
|||
Acquisition of additional investment in associate |
||||
Impairment loss |
( |
|||
Balance at December 31, 2025 |
$ |
|||
Fair value of investment in associate as at December 31, 2025 |
$ |
December 31, 2025 |
December 31, 2024 | |||||||
Cash |
$ |
$ | ||||||
Other current assets |
||||||||
Marketable securities |
||||||||
Non-current assets |
||||||||
Total assets |
$ |
$ | ||||||
Current liabilities |
||||||||
Non-current liabilities |
||||||||
Total liabilities |
$ |
$ | |
|||||
Year ended Dec 31, 2025 |
Year ended Dec 31, 2024 |
|||||||
Net loss |
$ |
( |
$ | ( |
||||
Other comprehensive income (loss) |
$ |
( |
$ | |||||
Total comprehensive loss |
$ |
( |
$ | ( |
||||
8. |
STRATEGIC INVENTORY |
9. |
CONVERTIBLE DEBENTURES |
2024 Debentures |
2023 Debentures |
Total | ||||||||||
Fair value at December 31, 2023 |
$ |
$ |
$ |
|||||||||
Fair value on issuance |
||||||||||||
Fair value adjustment |
( |
( |
( |
|||||||||
Fair value at December 31, 2024 |
$ |
$ |
$ |
|||||||||
Fair value adjustment |
||||||||||||
Fair Value at December 31, 2025 |
$ |
$ |
$ |
|||||||||
December 31, 2025 |
December 31, 2024 | |||||||
Volatility |
||||||||
Expected life |
||||||||
Risk free interest rate |
||||||||
Expected dividend yield |
||||||||
Credit spread |
||||||||
Underlying share price of the Company |
US$ |
US$ |
||||||
Conversion exercise price |
US$ |
US$ |
||||||
Exchange rate (C$:US$) |
$ |
$ |
||||||
December 31, 2025 |
December 31, 2024 |
|||||||
Volatility |
||||||||
Expected life |
4.4 years |
|||||||
Risk free interest rate |
||||||||
Expected dividend yield |
||||||||
Credit spread |
||||||||
Underlying share price of the Company |
US$ |
US$ |
||||||
Conversion exercise price |
US$ |
US$ |
||||||
Exchange rate (C$:US$) |
$ |
$ |
||||||
10. |
SHARE CAPITAL |
(a) |
Authorized capital |
(b) |
Share options |
Options outstanding |
Weighted average exercise price (C$) | |||||||
As at December 31, 2023 |
$ | |||||||
Granted |
||||||||
Exercised |
( |
|||||||
Forfeited |
( |
|||||||
As at December 31, 2024 |
$ | |||||||
Granted |
||||||||
Exercised |
( |
|||||||
Expired |
( |
|||||||
Forfeited |
( |
|||||||
At December 31, 2025 - Outstanding |
$ |
|||||||
At December 31, 2025 - Exercisable |
$ |
|||||||
Options Outstanding |
Options Exercisable |
|||||||||||||||||
Range of exercise price |
Weighted average remaining contractual life (years) |
Number of options |
Weighted average exercise price |
Number of options |
Weighted average exercise price |
|||||||||||||
$ $ |
$ | $ | ||||||||||||||||
$ |
$ | $ | ||||||||||||||||
| $ |
$ | $ | ||||||||||||||||
$ |
$ | $ | ||||||||||||||||
$ |
$ |
|||||||||||||||||
Twelve months ended Dec 31, | ||||||||
2025 |
2024 | |||||||
Expected stock price volatility |
||||||||
Expected life of options |
||||||||
Risk free interest rate |
||||||||
Expected forfeitures |
||||||||
Expected dividend yield |
||||||||
Weighted average fair value per option granted in period |
$ | $ | ||||||
Weighted average exercise price |
$ | $ | ||||||
11. |
SUPPLEMENTAL CASH FLOW INFORMATION |
Twelve months ended Dec 31, | ||||||||
2025 |
2024 | |||||||
Capitalized share-based payments |
$ |
$ | ||||||
Exploration and evaluation asset expenditures included in accounts payable and accrued liabilities |
( |
|||||||
Interest expense included in accounts payable and accrued liabilities |
||||||||
Decommissioning and restoration provision included in exploration and evaluation assets |
– | |||||||
Shares issued for convertible debenture interest payments |
( |
( |
||||||
Lease extension |
– | |||||||
Issuance of convertible debentures |
– | |||||||
Purchase of U 3 O8 strategic inventory |
– | ( |
||||||
12. |
RELATED PARTY TRANSACTIONS |
Twelve months ended Dec 31, |
||||||||
2025 |
2024 | |||||||
Short-term compensation (1) |
$ |
$ | ||||||
Share-based payments (2) |
||||||||
Consulting fees (3) |
||||||||
$ |
$ | |
||||||
13. |
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT |
● |
Level 1 - unadjusted quoted prices in active markets for identical assets or liabilities |
● |
Level 2 - inputs other than quoted prices that are observable for the asset or liability either directly or indirectly; and |
● |
Level 3 - inputs that are not based on observable market data. |
December 31, 2025 |
December 31, 2024 | |||||||
Cash |
$ |
$ | ||||||
Short-term investments |
– | |||||||
Amounts receivable |
||||||||
Lease receivable |
||||||||
Restricted cash |
– | |||||||
$ |
$ | |||||||
Less than 1 year |
1 to 3 years |
4 to 5 years |
Over 5 years |
Total | ||||||||||||||||
Accounts payable and accrued liabilities |
$ | $ | $ | $ | $ |
|||||||||||||||
Interest payable |
$ |
|||||||||||||||||||
Convertible debentures (Note 9) |
||||||||||||||||||||
Lease liabilities |
|
|
|
|
||||||||||||||||
$ |
$ |
$ |
$ |
$ |
||||||||||||||||
14. |
INCOME TAXES |
2025 |
2024 | |||||||
Net income (loss) before taxes for the year |
$ |
( |
) |
$ | ( |
) | ||
Statutory rate |
% |
% | ||||||
Expected income tax expense (recovery) |
$ |
( |
) |
$ | ( |
) | ||
Permanent differences |
||||||||
Impact of (gain) loss recognized in other comprehensive income |
( |
) | ||||||
Impact of (gain) loss on convertible debentures |
( |
) | ||||||
Change in unrecognized deductible temporary differences |
||||||||
Deferred income tax expense (recovery) |
$ |
$ | ( |
) | ||||
2025 |
2024 | |||||||
Deferred income tax expense (recovery) |
$ |
$ | ( |
) | ||||
Total |
$ |
$ | ( |
) | ||||
2025 |
2024 | |||||||
Change in fair value of convertible debentures attributable to the change in credit risk |
$ |
( |
) |
$ | ||||
Share of other comprehensive income (loss) of associate |
||||||||
Deferred tax expense (recovery) charged to OCI |
$ |
( |
) |
$ | ||||
2025 |
2024 | |||||||
Exploration and evaluation assets |
$ |
$ | ||||||
Convertible debentures |
||||||||
Non-capital losses |
( |
) |
( |
) | ||||
Investment in associate |
||||||||
Net deferred tax liabilities |
$ |
$ | ||||||
2025 |
2024 | |||||||
Opening balance |
$ |
$ | ||||||
Recognized in income tax expense (recovery) |
( |
) | ||||||
Recognized in OCI/equity |
( |
) |
||||||
Net deferred tax liabilities |
$ |
$ | ||||||
Temporary Differences |
2025 |
Expiry Date Range |
2024 | Expiry Date Range | ||||||||
Non-capital losses available for future periods |
$ |
2030 to 2045 |
$ | |||||||||
Convertible debentures |
– |
– | ||||||||||
Other |
– |
– | ||||||||||
15. |
SEGMENTED INFORMATION |
16. |
SUBSEQUENT EVENTS |